Skeletal muscle mitochondrial uncoupling prevents diabetes but not obesity in NZO mice, a model for polygenic diabesity

[1]  D. Vance,et al.  Adverse hepatic and cardiac responses to rosiglitazone in a new mouse model of type 2 diabetes: relation to dysregulated phosphatidylcholine metabolism. , 2006, Vascular pharmacology.

[2]  A. Schürmann,et al.  Uncoupling protein 1 expression in murine skeletal muscle increases AMPK activation, glucose turnover, and insulin sensitivity in vivo. , 2008, Physiological genomics.

[3]  S. Kliewer,et al.  The starvation hormone, fibroblast growth factor-21, extends lifespan in mice , 2012, eLife.

[4]  R. Selgas,et al.  Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21. , 2012, European journal of endocrinology.

[5]  J. Eckel,et al.  Myokines in insulin resistance and type 2 diabetes , 2014, Diabetologia.

[6]  Ortlepp,et al.  A metabolic syndrome of hypertension, hyperinsulinaemia and hypercholesterolaemia in the New Zealand obese mouse , 2000, European journal of clinical investigation.

[7]  R. Wehr,et al.  Expression of uncoupling protein 1 in skeletal muscle decreases muscle energy efficiency and affects thermoregulation and substrate oxidation. , 2005, Physiological genomics.

[8]  Matthias Blüher,et al.  Positional Cloning of Zinc Finger Domain Transcription Factor Zfp69, a Candidate Gene for Obesity-Associated Diabetes Contributed by Mouse Locus Nidd/SJL , 2009, PLoS genetics.

[9]  K. Mounzih,et al.  Effect of the genetic background on the reproduction of leptin-deficient obese mice. , 1999, Endocrinology.

[10]  H. Pan,et al.  A polymorphism in New Zealand inbred mouse strains that inactivates phosphatidylcholine transfer protein , 2006, FEBS letters.

[11]  A. Voigt,et al.  Dietary effects on body composition, glucose metabolism, and longevity are modulated by skeletal muscle mitochondrial uncoupling in mice , 2011, Aging cell.

[12]  J. Keijer,et al.  Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine. , 2014, American journal of physiology. Endocrinology and metabolism.

[13]  L. Nolte,et al.  Respiratory Uncoupling Lowers Blood Pressure Through a Leptin-Dependent Mechanism in Genetically Obese Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[14]  M. Blüher,et al.  Loss of function of Ifi202b by a microdeletion on chromosome 1 of C57BL/6J mice suppresses 11β-hydroxysteroid dehydrogenase type 1 expression and development of obesity. , 2012, Human molecular genetics.

[15]  A. Schürmann,et al.  Characterisation of the mouse diabetes susceptibility locus Nidd/SJL: islet cell destruction, interaction with the obesity QTL Nob1, and effect of dietary fat , 2002, Diabetologia.

[16]  R. Crescenzo,et al.  Mitochondrial efficiency and insulin resistance , 2015, Front. Physiol..

[17]  Jan Nedergaard,et al.  Chronic Peroxisome Proliferator-activated Receptor γ (PPARγ) Activation of Epididymally Derived White Adipocyte Cultures Reveals a Population of Thermogenically Competent, UCP1-containing Adipocytes Molecularly Distinct from Classic Brown Adipocytes* , 2009, The Journal of Biological Chemistry.

[18]  N. Petrovic,et al.  UCP1 in brite/beige adipose tissue mitochondria is functionally thermogenic. , 2013, Cell reports.

[19]  P. Seale,et al.  Brown and beige fat: development, function and therapeutic potential , 2013, Nature Medicine.

[20]  C. Goodall,et al.  Origin of inbred NZ mouse strains. , 1970, Cancer research.

[21]  S. Klaus,et al.  Body weight and energy homeostasis was not affected in C57BL/6 mice fed high whey protein or leucine-supplemented low-fat diets , 2011, European journal of nutrition.

[22]  A. Schürmann,et al.  Dissociation of lipotoxicity and glucotoxicity in a mouse model of obesity associated diabetes: role of forkhead box O1 (FOXO1) in glucose-induced beta cell failure , 2010, Diabetologia.

[23]  H. Vogel,et al.  Characterization of Nob3, a major quantitative trait locus for obesity and hyperglycemia on mouse chromosome 1. , 2009, Physiological genomics.

[24]  K. Mounzih,et al.  Leptin-deficient mice backcrossed to the BALB/cJ genetic background have reduced adiposity, enhanced fertility, normal body temperature, and severe diabetes. , 2001, Endocrinology.

[25]  J. Heeren,et al.  Adipose tissue browning and metabolic health , 2014, Nature Reviews Endocrinology.

[26]  The genetic basis of obesity-associated type 2 diabetes (diabesity) in polygenic mouse models , 2014, Mammalian Genome.

[27]  M. Portero-Otín,et al.  Muscle mitohormesis promotes cellular survival via serine/glycine pathway flux , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  J. Altirriba,et al.  Brown adipose tissue activity as a target for the treatment of obesity/insulin resistance , 2015, Front. Physiol..

[29]  H. Ohta,et al.  Roles of FGFs as Adipokines in Adipose Tissue Development, Remodeling, and Metabolism , 2014, Front. Endocrinol..

[30]  Rob C Hoeben,et al.  Tbc1d1 mutation in lean mouse strain confers leanness and protects from diet-induced obesity , 2008, Nature Genetics.

[31]  F. Villarroya,et al.  TNF-α represses β-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway. , 2012, Endocrinology.

[32]  D. Reed,et al.  Reduced body weight is a common effect of gene knockout in mice , 2008, BMC Genetics.

[33]  R. Gimeno,et al.  The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue. , 2013, Molecular metabolism.

[34]  Thomas M. Keane,et al.  Mouse genomic variation and its effect on phenotypes and gene regulation , 2011, Nature.

[35]  D. Moller,et al.  Fibroblast growth factor 21 corrects obesity in mice. , 2008, Endocrinology.

[36]  S. Kliewer,et al.  Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. , 2008, Cell metabolism.

[37]  N. Turner,et al.  Mitochondrial dysfunction and insulin resistance: an update , 2014, Endocrine connections.

[38]  R. Gimeno,et al.  Discrete Aspects of FGF21 In Vivo Pharmacology Do Not Require UCP1. , 2015, Cell reports.

[39]  B. Taylor,et al.  Multiple obesity QTLs identified in an intercross between the NZO (New Zealand obese) and the SM (small) mouse strains , 2001, Mammalian Genome.

[40]  M. Reitman,et al.  Genetic background (C57BL/6J versus FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice. , 2004, Endocrinology.

[41]  J. Gromada,et al.  FGF-21 as a novel metabolic regulator. , 2005, The Journal of clinical investigation.

[42]  H. Joost.  The genetic basis of obesity and type 2 diabetes: lessons from the new zealand obese mouse, a polygenic model of the metabolic syndrome. , 2010, Results and problems in cell differentiation.

[43]  A. Adams,et al.  Inventing new medicines: The FGF21 story☆ , 2013, Molecular metabolism.

[44]  D. Ron,et al.  Endoplasmic reticulum stress signaling in disease. , 2006, Physiological reviews.

[45]  J. Ju,et al.  Skeletal muscle respiratory uncoupling prevents diet-induced obesity and insulin resistance in mice , 2000, Nature Medicine.

[46]  W. Mckeehan,et al.  Stressed Liver and Muscle Call on Adipocytes with FGF21 , 2013, Front. Endocrinol..

[47]  A. Bigard,et al.  High Level of Uncoupling Protein 1 Expression in Muscle of Transgenic Mice Selectively Affects Muscles at Rest and Decreases Their IIb Fiber Content* , 2002, The Journal of Biological Chemistry.

[48]  M. Véniant,et al.  Pharmacologic Effects of FGF21 Are Independent of the "Browning" of White Adipose Tissue. , 2015, Cell metabolism.

[49]  Joseph H. Nadeau,et al.  Modifier genes in mice and humans , 2001, Nature Reviews Genetics.

[50]  Sylvia Ortmann,et al.  Hyperphagia, lower body temperature, and reduced running wheel activity precede development of morbid obesity in New Zealand obese mice. , 2006, Physiological genomics.

[51]  E. Leiter,et al.  NIDDM Genes in Mice: Deleterious Synergism by Both Parental Genomes Contributes to Diabetogenic Thresholds , 1998, Diabetes.

[52]  G. Williams,et al.  Correlation between the glucose clamp technique and the homeostasis model assessment in hypertension. , 2001, American journal of hypertension.

[53]  A. Voigt,et al.  Identification of Mest/Peg1 gene expression as a predictive biomarker of adipose tissue expansion sensitive to dietary anti-obesity interventions , 2015, Genes & Nutrition.

[54]  J. Flier,et al.  Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State , 2010, Diabetes.

[55]  M. Tschöp,et al.  Development of diabetes in obese, insulin-resistant mice: essential role of dietary carbohydrate in beta cell destruction , 2007, Diabetologia.

[56]  A. Voigt,et al.  Skeletal muscle uncoupling-induced longevity in mice is linked to increased substrate metabolism and induction of the endogenous antioxidant defense system. , 2013, American journal of physiology. Endocrinology and metabolism.

[57]  H. Vogel,et al.  An Interval of the Obesity QTL Nob3.38 within a QTL Hotspot on Chromosome 1 Modulates Behavioral Phenotypes , 2013, PloS one.

[58]  A. Voigt,et al.  Activation of AMPKα2 Is Not Crucial for Mitochondrial Uncoupling-Induced Metabolic Effects but Required to Maintain Skeletal Muscle Integrity , 2014, PloS one.

[59]  A. Wagers,et al.  Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat , 2010, Proceedings of the National Academy of Sciences.

[60]  S. Klaus,et al.  Dissociation of obesity and insulin resistance in transgenic mice with skeletal muscle expression of uncoupling protein 1. , 2008, Physiological genomics.

[61]  Jing Xu,et al.  FGF21 Promotes Metabolic Homeostasis via White Adipose and Leptin in Mice , 2012, PloS one.